The use of psychedelics as medicines and for overall better brain health is potentially one of the most
transformative developments given their immediate and long-lasting therapeutic effects across a plethora
of neuropsychiatric disorders and, more recently, some neurodegenerative diseases. The US psychedelic
drugs market is forecasted to grow by 16.3% by 2027 due to the increasing prevalence of treatmentresistant depression and mental health disorders. Decades-long restrictions, which date back to when
psychedelics were declared controlled substances in 1970, have been lifted to allow researchers to publish
on the therapeutic benefits of psychedelics. This review will feature the incredible depth of research
underway revealing how psychedelics impact brain structure and function to treat mental health and
other neurological disorders. CLICK TO REVIEW